Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Maor

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
American Journal of Hematology|February 1, 1996
Burkitt's lymphoma in a patient with recurrent pericarditisY Maor-Kendler, A Shimoni, M Prokocimer
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|August 14, 1999
Comparing medical centers treating hip fractures in the elderly: the importance of multi-outcome measurementsB Mozes, Y Maor, L Olmer, et al.
Fertility and Sterility|November 1, 1979
A progressive rise in serum copper levels in women taking oral contraceptives: a potential hazard?Y Rubinfeld, Y Maor, D Simon, et al.
Chest|December 14, 1999
Factors associated with health indicators in patients undergoing coronary artery bypass surgeryY Maor, Y Cohen, L Olmer, et al.
Journal of Clinical Epidemiology|May 30, 2001
A comparison of three measures: the time trade-off technique, global health-related quality of life and the SF-36 in dialysis patientsY Maor, M King, L Olmer, et al.
Journal of Health Services Research & Policy|December 8, 1997
The importance of laboratory data for comparing outcomes and detecting 'outlier' wards in the treatment of patients with pneumoniaY Maor, H R Rubin, U Gabbai, et al.
Lancet (London, England)|September 17, 1994
Frequency of intercourse for couples trying to conceiveI Tur-Kaspa, Y Maor, J Dor, et al.
The Journal of Experimental Medicine|February 1, 1992
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptorsD Aderka, H Engelmann, Y Maor, et al.
The Israel Medical Association Journal : IMAJ|September 9, 2000
Skeletal sarcoidosis: successful treatment with hydroxychloroquineA Shimoni, T Hershcovici, S Mekhmandarov, et al.
British Journal of Pharmacology|July 24, 2010
Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediatorX Zhang, Y Maor, J F Wang, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
American Journal of Hematology|February 1, 1996
Burkitt's lymphoma in a patient with recurrent pericarditisY Maor-Kendler, A Shimoni, M Prokocimer
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|August 14, 1999
Comparing medical centers treating hip fractures in the elderly: the importance of multi-outcome measurementsB Mozes, Y Maor, L Olmer, et al.
Fertility and Sterility|November 1, 1979
A progressive rise in serum copper levels in women taking oral contraceptives: a potential hazard?Y Rubinfeld, Y Maor, D Simon, et al.
Chest|December 14, 1999
Factors associated with health indicators in patients undergoing coronary artery bypass surgeryY Maor, Y Cohen, L Olmer, et al.
Journal of Clinical Epidemiology|May 30, 2001
A comparison of three measures: the time trade-off technique, global health-related quality of life and the SF-36 in dialysis patientsY Maor, M King, L Olmer, et al.
Journal of Health Services Research & Policy|December 8, 1997
The importance of laboratory data for comparing outcomes and detecting 'outlier' wards in the treatment of patients with pneumoniaY Maor, H R Rubin, U Gabbai, et al.
Lancet (London, England)|September 17, 1994
Frequency of intercourse for couples trying to conceiveI Tur-Kaspa, Y Maor, J Dor, et al.
The Journal of Experimental Medicine|February 1, 1992
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptorsD Aderka, H Engelmann, Y Maor, et al.
The Israel Medical Association Journal : IMAJ|September 9, 2000
Skeletal sarcoidosis: successful treatment with hydroxychloroquineA Shimoni, T Hershcovici, S Mekhmandarov, et al.
British Journal of Pharmacology|July 24, 2010
Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediatorX Zhang, Y Maor, J F Wang, et al.
Pageof 4